<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="89134">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02033252</url>
  </required_header>
  <id_info>
    <org_study_id>NCRC-KIM-02</org_study_id>
    <nct_id>NCT02033252</nct_id>
  </id_info>
  <brief_title>Acupuncture for Rhinitis Complicated With Asthma</brief_title>
  <official_title>Acupuncture for Persistent Allergic Rhinitis Complicated With Asthma, A Randomized Controlled Pilot Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jun-Yong Choi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korean Medicine Hospital of Pusan National University</source>
  <oversight_info>
    <authority>Republic of Korea: Ministry of Food And Drug Safety</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled study aimed to evaluate the efficacy and safety of acupuncture
      therapy on persistent allergic rhinitis patients complicated with asthma.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Total Nasal Symptom Score, TNSS</measure>
    <time_frame>Change from Baseline TNSS Score at 4 Weeks after Randomization</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rhinitis Quality of Life Questionnaire, RQLQ</measure>
    <time_frame>Change from Baseline at 2 Weeks after Randomization (Both Groups), Change from Baseline at 4 Weeks after Randomization (Both Groups), Change from Baseline at 8 Weeks after Randomization (Active Group Only)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire for adult Korean Asthmatics, QLQAKA</measure>
    <time_frame>Change from Baseline at 2 Weeks after Randomization (Both Groups), Change from Baseline at 4 Weeks after Randomization (Both Groups), Change from Baseline at 8 Weeks after Randomization (Active Group Only)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>Change from Baseline at 2 Weeks after Randomization (Both Groups), Change from Baseline at 4 Weeks after Randomization (Both Groups), Change from Baseline at 8 Weeks after Randomization (Active Group Only)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function test, PFT</measure>
    <time_frame>Baseline, four weeks after randomization (both groups)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQoL-5 Dimention Questionnaire, EQ-5D</measure>
    <time_frame>Baseline, four weeks after randomization</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Nasal Symptom Score, TNSS</measure>
    <time_frame>Change from Baseline at 2 Weeks after Randomization (Both Groups), Change from Baseline at 8 Weeks after Randomization (Active Group Only)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Allergic Rhinitis</condition>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A series of acupuncture sessions within four weeks from the baseline with concurrent conventional medications for asthma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waiting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants who will be allocated to waitlist will receive no acupuncture treatments throughout the 4 weeks while receiving other conventional managements for asthma. After 4 weeks, if participants choose to try the acupuncture treatment, the active acupuncture treatment will be provided for 4 weeks (3 sessions/week).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>In the acupuncture treatment group, 10 acupuncture points (bilateral LI4, TE23, ST36, unilateral EHN-1, GV23, LI20 and LI4) will be inserted with 0.20 mm in diameter x 30 mm in length disposal needles. The needle will be inserted to a depth of 10 - 30 mm, according to the points selected. The participating acupuncture doctors will manually manipulate the acupuncture needles with de-qi sensation and maintain the needles for 10 minutes with two times of manual stimulation, at the beginning and at the end.</description>
    <arm_group_label>Acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Suffering from persistent Allergic rhinitis (PAR; nasal obstruction, rhinorrhoea,
             sneezing and nasal itching) symptoms for more than 4 days/week, and greater than 4
             consecutive weeks.

          2. Moderate-severe symptoms according to Allergic rhinitis and its impact on asthma
             (ARIA) criteria.

          3. Positive reaction for more than or equal to one respiratory allergen (SPT or MAST)

          4. Stable asthma symptoms with diagnosis of Asthma by respiratory or allergic disease
             specialist.

          5. No changes in asthma or allergic rhinitis drugs for the past month

          6. Aged greater than or equal to 18 years, either sex.

          7. No problem with expression of opinion

          8. Provided with written consent

          9. No other disease except allergic rhinitis or asthma which could affect the disease.

        Exclusion Criteria:

          1. Having experience using ventilator due to exacerbation of asthma symptoms within six
             months.

          2. Experience of acute respiratory tract infection treated with antibiotics within 14
             days

          3. Having anatomical occlusion or deformation in nasal cavity.

          4. Signs of infection in chest X-ray or having active respiratory disease except asthma

          5. Below or equal to 4 on Total nasal symptom score (TNSS) in the latest week.

          6. Received drugs affecting directly to allergic rhinitis such as H1-antihistamines,
             decongestants (nasal, oral or ocular), corticosteroids within 14 days.

          7. Received following treatments for allergic rhinitis or asthma within six months ;
             Traditional Korean medicine interventions such as acupuncture, moxibustion, cupping
             therapy and herbal medication inhalation or CAM including homeopathy.

          8. Received herbal medication for allergic rhinitis or asthma within 14 days.

          9. Pregnant, planning the pregnancy or breast-feeding

         10. Tuberculosis, hepatitis or more than 2 x normal limit of serum creatinine, AST/ALT.

         11. Skin lesion on acupoint or other systemic disease insufficient for acupuncture.

         12. Night-shift workers staying up all night

         13. Who cannot participate clinical trial properly.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun-Yong Choi, KMD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korean Medicine Hospital, Pusan National University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yun Seong Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yangsan Pusan National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seung Eun Lee, MD</last_name>
    <role>Study Director</role>
    <affiliation>Yangsan Pusan National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Minjoo Kang, BcS</last_name>
    <phone>82553605907</phone>
    <email>syblkmj@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Clinical Research Center, Korean Medicine Hospital, Pusan National University</name>
      <address>
        <city>Yangsan</city>
        <state>Kyungsangnamdo</state>
        <zip>626-770</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Jin Kim, BcS</last_name>
      <phone>82553605902</phone>
      <email>djkim085@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jun Yong Choi, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 9, 2014</lastchanged_date>
  <firstreceived_date>January 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Korean Medicine Hospital of Pusan National University</investigator_affiliation>
    <investigator_full_name>Jun-Yong Choi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Asthma</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
